Syneron Candela Announces CE Mark for CO2RE® Intima
CO2RE Intima Now First In-Office Laser Procedure CE Marked for the Treatment of Vaginal Atrophy and Rejuvenation IRVINE, California, March 27, 2017 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that the company secured the CE Mark...
Syneron Candela Announces New FDA Clearance for the CO2RE System
IRVINE, Calif., Nov. 5, 2015 /PRNewswire/ -- Syneron Medical Ltd.
(NASDAQ: ELOS), a global market leader in the aesthetic medical device
marketplace, announced today that the US Food and Drug Administration (FDA) has
granted numerous additional indications for use of theCO2RE
Syneron Candela Announces the Launch of PicoWay Resolve at EADV
WAYLAND, Mass., Oct. 9, 2015 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ:
ELOS), a global market leader in the aesthetic medical device marketplace,
announced today the international launch of PicoWay Resolve™, the revolutionary
dual wavelength fractional modality for thePicoWay
Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser
IRVINE, Calif., July 28, 2015 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, announced today that it has received Korean Ministry of Food and Drug Safety (MFDS) regulatory clearance for the PicoWay® picosecond laser. With t...
Syneron Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance for Treatment of Pigmented Lesions
YOKNEAM, Israel, April 21, 2015 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, announced today that the PicoWay® picosecond laser received U.S. Food and Drug Administration (FDA) clearance for the treatment of pigmented les...
UltraShape Wins NewBeauty Magazine Beauty Choice Award For Best Body-Contouring Treatment
WAYLAND, Mass., Jan. 16, 2015 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ:
ELOS), a leading global aesthetic device company, announced today that NewBeauty
Magazine awardedUltraShape
Syneron Announces Launch of PicoWay Picosecond Device for Pigmented Lesion Treatment and Tattoo Removal
WAYLAND, Massachusetts, Oct. 8, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today the international launch of the new PicoWay™ picosecond device at the 23rd European Academy of Dermatology and Venereology (EADV) Congress inAmsterda...
Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions
HONG KONG, July 28, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that its new PicoWay® device has received CE Mark indication to treat tattoos of all types and colors and pigmented lesions on any skin type. PicoWay is a new...
A new roadmap: Equinox Blueprint provides vision for 21st century education
-- Equinox Blueprint urges focus on high school as UN Millennium Development Goals reach deadline OXFORD, England, April 16, 2014 /PRNewswire/ -- Across the globe there is a growing recognition that 2014 is a watershed year for change in education. To address this need for change, Equinox Bluep...
Syneron Receives US FDA Clearance to Market the UltraShape System for Fat Cell Destruction
IRVINE, Calif., April 16, 2014 /PRNewswire/ -- Positions Syneron with Disruptive Product Offering in Fast Growing Body Contouring and Fat Treatment Market Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, announced today that it has received ...
Syneron Medical Introduces Next Generation Handpieces for Gentle Pro Laser Hair Removal and elos Plus Systems
WAYLAND, Mass., Sept. 3, 2013 /PRNewswire/ -- Enhances Efficiency and Reduces Treatment Time Syneron Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device company, announced today the market launch of new applicators with expanded spot sizes for two of its best-selling platforms, Gen...
61% of Hong Kong Women are Concerned About Current Body Shape
HONG KONG, July 11, 2013 /PRNewswire/ -- Syneron Medical, a Global Leader in devices for aesthetic medicine to present latest technologies to meet growing demands for enhanced body beauty at 9th Asian Dermatological Congress in Hong Kong Syneron Medical Ltd. (NASDAQ: ELOS), a leading global ae...
Syneron Highlights New Products at IMCAS Asia Meeting
Includes Introduction of High-Energy eTwo System and Recently Launched Gentle Pro-U Series and elos Plus System YOKNEAM, Israel, Oct. 4, 2012 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device company, announced today that it is highlighting several new produ...
Syneron Announces Global Launch of Gentle Pro-U Series at the European Academy of Dermatology and Venereology Annual Congress
New Gentle Pro-U Series Allows Customers to Upgrade Systems to Dual Wavelength Configurations for Enhanced Performance and Additional Clinical Indications YOKNEAM, Israel, Sept. 27, 2012 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced to...
